Procalcitonin levels should not guide CAP diagnosis, treatment
According to the researchers, the complex etiology of community-acquired pneumonia (CAP) makes disease management difficult. "In cases of bacterial pneumonia, initial antibiotic treatment is important for infection resolution, and a shorter time between diagnosis and treatment improves prognosi...
Gespeichert in:
Veröffentlicht in: | Infectious Disease News 2019-08, Vol.32 (8), p.38-38 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 38 |
---|---|
container_issue | 8 |
container_start_page | 38 |
container_title | Infectious Disease News |
container_volume | 32 |
creator | Ghizzone, Marley Molloy, Leah |
description | According to the researchers, the complex etiology of community-acquired pneumonia (CAP) makes disease management difficult. "In cases of bacterial pneumonia, initial antibiotic treatment is important for infection resolution, and a shorter time between diagnosis and treatment improves prognosis," Ishan S. Kamat, MD, MBA, internal medicine resident at Baylor College of Medicine, and colleagues wrote. Unlike manufacturer-proposed algorithms associating procalcitonin concentrations greater than 0.25 pg/L with bacterial infections, this analysis used a higher threshold of 0.5 pg/L, but noted consistently poor performance across a range of values. Because atypical bacteria are associated with lower procalcitonin concentrations than typical bacteria, including both may have reduced the performance of the test compared with differentiating viruses from typical bacteria only. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_2273103872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2273103872</sourcerecordid><originalsourceid>FETCH-proquest_reports_22731038723</originalsourceid><addsrcrecordid>eNqNyrEOgjAQANAOmojiP1ycJSktiC4mhmgcGdxJAyfW1B72it_v4gc4veXNRJLLcpcdVJkvxJL5KWWhy0In4tgE6ozrbCRvPTj8oGPgB02uB08Rhsn2CPWpgd6awRNb3kIMaOILfUzF_G4c4_rnSmwu51t9zcZA7wk5tgFHCpFbpSqdS72vlP4rfQHkUzb0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2273103872</pqid></control><display><type>article</type><title>Procalcitonin levels should not guide CAP diagnosis, treatment</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Ghizzone, Marley ; Molloy, Leah</creator><creatorcontrib>Ghizzone, Marley ; Molloy, Leah</creatorcontrib><description>According to the researchers, the complex etiology of community-acquired pneumonia (CAP) makes disease management difficult. "In cases of bacterial pneumonia, initial antibiotic treatment is important for infection resolution, and a shorter time between diagnosis and treatment improves prognosis," Ishan S. Kamat, MD, MBA, internal medicine resident at Baylor College of Medicine, and colleagues wrote. Unlike manufacturer-proposed algorithms associating procalcitonin concentrations greater than 0.25 pg/L with bacterial infections, this analysis used a higher threshold of 0.5 pg/L, but noted consistently poor performance across a range of values. Because atypical bacteria are associated with lower procalcitonin concentrations than typical bacteria, including both may have reduced the performance of the test compared with differentiating viruses from typical bacteria only.</description><identifier>ISSN: 1056-9251</identifier><language>eng</language><publisher>Thorofare: SLACK INCORPORATED</publisher><subject>Antibiotics ; Bacteria ; Bacterial infections ; Etiology ; Financial disclosure ; Infections ; Infectious diseases ; Pneumonia ; Researchers ; Viral infections</subject><ispartof>Infectious Disease News, 2019-08, Vol.32 (8), p.38-38</ispartof><rights>Copyright SLACK INCORPORATED Aug 2019</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,780,784,791</link.rule.ids></links><search><creatorcontrib>Ghizzone, Marley</creatorcontrib><creatorcontrib>Molloy, Leah</creatorcontrib><title>Procalcitonin levels should not guide CAP diagnosis, treatment</title><title>Infectious Disease News</title><description>According to the researchers, the complex etiology of community-acquired pneumonia (CAP) makes disease management difficult. "In cases of bacterial pneumonia, initial antibiotic treatment is important for infection resolution, and a shorter time between diagnosis and treatment improves prognosis," Ishan S. Kamat, MD, MBA, internal medicine resident at Baylor College of Medicine, and colleagues wrote. Unlike manufacturer-proposed algorithms associating procalcitonin concentrations greater than 0.25 pg/L with bacterial infections, this analysis used a higher threshold of 0.5 pg/L, but noted consistently poor performance across a range of values. Because atypical bacteria are associated with lower procalcitonin concentrations than typical bacteria, including both may have reduced the performance of the test compared with differentiating viruses from typical bacteria only.</description><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Etiology</subject><subject>Financial disclosure</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Pneumonia</subject><subject>Researchers</subject><subject>Viral infections</subject><issn>1056-9251</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNyrEOgjAQANAOmojiP1ycJSktiC4mhmgcGdxJAyfW1B72it_v4gc4veXNRJLLcpcdVJkvxJL5KWWhy0In4tgE6ozrbCRvPTj8oGPgB02uB08Rhsn2CPWpgd6awRNb3kIMaOILfUzF_G4c4_rnSmwu51t9zcZA7wk5tgFHCpFbpSqdS72vlP4rfQHkUzb0</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Ghizzone, Marley</creator><creator>Molloy, Leah</creator><general>SLACK INCORPORATED</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20190801</creationdate><title>Procalcitonin levels should not guide CAP diagnosis, treatment</title><author>Ghizzone, Marley ; Molloy, Leah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_22731038723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Etiology</topic><topic>Financial disclosure</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Pneumonia</topic><topic>Researchers</topic><topic>Viral infections</topic><toplevel>online_resources</toplevel><creatorcontrib>Ghizzone, Marley</creatorcontrib><creatorcontrib>Molloy, Leah</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Infectious Disease News</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghizzone, Marley</au><au>Molloy, Leah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Procalcitonin levels should not guide CAP diagnosis, treatment</atitle><jtitle>Infectious Disease News</jtitle><date>2019-08-01</date><risdate>2019</risdate><volume>32</volume><issue>8</issue><spage>38</spage><epage>38</epage><pages>38-38</pages><issn>1056-9251</issn><abstract>According to the researchers, the complex etiology of community-acquired pneumonia (CAP) makes disease management difficult. "In cases of bacterial pneumonia, initial antibiotic treatment is important for infection resolution, and a shorter time between diagnosis and treatment improves prognosis," Ishan S. Kamat, MD, MBA, internal medicine resident at Baylor College of Medicine, and colleagues wrote. Unlike manufacturer-proposed algorithms associating procalcitonin concentrations greater than 0.25 pg/L with bacterial infections, this analysis used a higher threshold of 0.5 pg/L, but noted consistently poor performance across a range of values. Because atypical bacteria are associated with lower procalcitonin concentrations than typical bacteria, including both may have reduced the performance of the test compared with differentiating viruses from typical bacteria only.</abstract><cop>Thorofare</cop><pub>SLACK INCORPORATED</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1056-9251 |
ispartof | Infectious Disease News, 2019-08, Vol.32 (8), p.38-38 |
issn | 1056-9251 |
language | eng |
recordid | cdi_proquest_reports_2273103872 |
source | Free E-Journal (出版社公開部分のみ) |
subjects | Antibiotics Bacteria Bacterial infections Etiology Financial disclosure Infections Infectious diseases Pneumonia Researchers Viral infections |
title | Procalcitonin levels should not guide CAP diagnosis, treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A53%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Procalcitonin%20levels%20should%20not%20guide%20CAP%20diagnosis,%20treatment&rft.jtitle=Infectious%20Disease%20News&rft.au=Ghizzone,%20Marley&rft.date=2019-08-01&rft.volume=32&rft.issue=8&rft.spage=38&rft.epage=38&rft.pages=38-38&rft.issn=1056-9251&rft_id=info:doi/&rft_dat=%3Cproquest%3E2273103872%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2273103872&rft_id=info:pmid/&rfr_iscdi=true |